Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics

Switzerland stories

Nov 16, 2026

FDA approves Roche's oral breast cancer pill Wilserdly

The FDA approved Roche's oral treatment for estrogen receptor-positive, HER2-negative advanced breast cancer, providing a new option for patients and a significant commercial boost for the Swiss drugmaker.

Nov 16, 2026·3 sources
00
Nov 13, 2026

Nigeria ends Ebola contact monitoring with no secondary transmission

Nigeria completed the 21-day monitoring period for all 62 contacts linked to a reported Ebola case, with none falling ill, signalling containment of the outbreak.

Nov 13, 2026·2 sources
00

Windward Bio prices $175M IPO to advance China-licensed lung drugs

Swiss immune drug developer Windward Bio raised $175 million in its IPO, the biotech sector's 30th listing of the year, to advance lung disease drugs licensed from China.

Nov 13, 2026·2 sources
00
Nov 10, 2026

FDA approves Merck KGaA's pimicotinib for tenosynovial giant cell tumor

The FDA has approved pimicotinib (Pimjetmi, EMD Serono) for treating symptomatic tenosynovial giant cell tumors where surgery would worsen functional limitations, marking another win for Merck KGaA's rare tumor strategy.

Nov 10, 2026·3 sources
00
Nov 6, 2026

vVardis dental firm seeks $228M in US IPO at up to $4.37B valuation

Swiss dental health company vVardis, backed by Apollo Global Management, is targeting a valuation of up to $4.37 billion in a US initial public offering seeking to raise up to $228.6 million.

Nov 6, 2026·2 sources
00
Nov 5, 2026

Infant vitamin K refusal linked to doubled risk of brain bleeds and death

A study published in JAMA found babies who did not receive a vitamin K shot at birth were more than twice as likely to experience intracranial bleeding and death, as parental refusal of the routine injection rises.

Nov 5, 2026·2 sources
00
Oct 31, 2026

Nigeria confirms two suspected Ebola cases test negative

Health authorities in Nigeria confirmed that two suspected Ebola cases in the northeast region tested negative after two rounds of testing.

Oct 31, 2026·2 sources
00
Oct 29, 2026

Stem cell transplants show 60% progression-free survival at 10 years for severe systemic sclerosis

An international study reports 60% progression-free survival at 10 years after autologous bone marrow transplantation in patients treated for early severe systemic sclerosis, providing evidence of sustained positive clinical outcomes and long-term safety for the rare autoimmune disease.

Oct 29, 2026·3 sources
00

ECDC report finds universal RSV immunization could significantly reduce infant hospitalizations in Europe

A new report from the European Centre for Disease Prevention and Control indicates that universal immunization of newborns against respiratory syncytial virus could significantly reduce infant hospitalizations across the EU. The findings come as the RSV season approaches, with evidence showing national programs using nirsevimab or maternal vaccination are associated with large reductions in infant hospitalizations.

Oct 29, 2026·2 sources
00
Oct 26, 2026

Congo Ebola cases surpass 10,000 as health worker killed in attack

Democratic Republic of Congo's Ebola outbreak has exceeded 10,000 confirmed cases, with violence against health workers intensifying after a nurse was killed responding to the epidemic.

Oct 26, 2026·2 sources
00

Switzerland reopens diplomatic office in North Korea after years of closure

Swiss Foreign Minister Ignazio Cassis will travel to North Korea this week for political talks and the formal reopening of Switzerland's diplomatic office in Pyongyang, the government announced Monday.

Oct 26, 2026·4 sources
00

Swiss court finds Belarusian man guilty over disappearance of Lukashenko opponent

A Swiss court found a former Belarusian security officer guilty over the abduction of businessman Anatoly Krasovsky, an opponent of Belarus President Alexander Lukashenko. The case highlights ongoing repression under the Lukashenko regime.

Oct 26, 2026·3 sources
00

Nigeria evacuates Ebola patient to Switzerland

Nigeria evacuated a woman who contracted Ebola to Switzerland for treatment, with health officials monitoring 52 contacts as the country works to contain the outbreak to a single infection cluster.

Oct 26, 2026·3 sources
00
Oct 20, 2026

Switzerland's FINMA approves first retail Bitcoin ETF

Switzerland's financial regulator FINMA approved the country's first retail exchange-traded fund that invests directly in Bitcoin, granting an exemption from standard diversification rules on the grounds that Bitcoin is sufficiently liquid.

Oct 20, 2026·7 sources
00
Oct 18, 2026

Vietnam signs free trade agreement with EFTA countries

Vietnam signed a free trade agreement with the European Free Trade Association (EFTA), comprising Norway, Switzerland, Iceland, and Liechtenstein, eliminating or reducing customs duties on industrial, fish, and agricultural products.

Oct 18, 2026·5 sources
00
Oct 5, 2026

Roche licenses Alector's Parkinson's disease therapy for up to $1.27 billion

Swiss drugmaker Roche will pay up to $1.27 billion to license Alector's experimental treatment for Parkinson's disease, with $100 million upfront. The deal sent Alector's shares surging over 70% in premarket trading.

Oct 5, 2026·4 sources
00
Oct 4, 2026

CSL strikes $1.6 billion rare disease drug deal with Alentis Therapeutics

Australian drugmaker CSL has entered an agreement with Swiss biotech Alentis Therapeutics to co-develop and co-promote lixudebart, a treatment for rare kidney and liver diseases. The deal includes $355 million upfront and up to $1.2 billion in milestone payments, excluding development funding.

Oct 4, 2026·5 sources
00
Sep 24, 2026

Roche signs drug discovery deal with Atavistik Bio worth up to $2 billion

Swiss drugmaker Roche has entered a partnership with Atavistik Bio potentially worth nearly $2 billion, including milestone payments, to develop oral treatments for cardiovascular, kidney and metabolic diseases. The deal includes $70 million upfront with an additional $1.9 billion in potential milestone payments.

Sep 24, 2026·6 sources
00
Sep 17, 2026

Russia seizes assets of Nestlé and French firms Auchan and Leroy Merlin

Russian President Vladimir Putin signed a decree placing the Russian subsidiaries of Swiss food giant Nestlé and French retailers Auchan and Leroy Merlin under temporary state administration, the latest move against Western companies operating in Russia.

Sep 17, 2026·8 sources
00
Sep 14, 2026

Swiss Bitcoin Pay shuts down servers after data breach exposes customer information

Swiss Bitcoin Pay, a non-custodial bitcoin payment processor based in Neuchâtel, shut down its entire server infrastructure on Monday after discovering a malicious intruder had gained access to its internal systems. The company warned that customer email addresses, Bitcoin addresses, IBANs, transaction history, and hashed passwords may have been compromised.

Sep 14, 2026·4 sources
00
Sep 11, 2026

Bitcoin Suisse to cut up to 60 Swiss jobs in international restructuring

Bitcoin Suisse announced plans to eliminate up to 60 of its 120 positions in Switzerland and close its Copenhagen development site as part of a strategic reorganization to expand international operations. The crypto financial services firm, founded in Zug in 2013, is shifting operations abroad.

Sep 11, 2026·3 sources
00
Sep 10, 2026

Coach crash in Switzerland kills several Dutch tourists

A tourist coach carrying Dutch nationals overturned in eastern Switzerland near the Alpine village of Susch, killing several people and injuring others.

Sep 10, 2026·10 sources
00

Novartis shareholder Artisan Partners calls for board shake-up after trial setbacks

Major Novartis shareholder Artisan Partners is demanding board changes and improved dealmaking after the Swiss drugmaker's shares suffered a record fall following three consecutive major clinical trial failures, raising questions about corporate governance and R&D strategy.

Sep 10, 2026·2 sources
00
Sep 8, 2026

Sandoz CEO warns Trump generic drug tariffs would raise costs for American patients

The CEO of Swiss pharmaceutical company Sandoz cautioned that President Donald Trump's threatened tariffs on generic drugs would ultimately be paid by American patients, as manufacturers could pass increased costs onto consumers.

Sep 8, 2026·1 source
00

Sandoz CEO warns Trump generic drug tariffs would raise costs for American patients

The CEO of Swiss pharmaceutical company Sandoz cautioned that President Donald Trump's threatened tariffs on generic drugs would ultimately be paid by American patients, as manufacturers could pass increased costs onto consumers.

Sep 8, 2026·1 source
00

Novartis shares plunge 10% after experimental neuromuscular drug fails late-stage trial

Swiss pharmaceutical giant Novartis saw its stock drop as much as 10% following the failure of an experimental neuromuscular treatment in a late-stage clinical trial. The setback comes just days after another high-profile trial failure in heart disease, marking the company's third recent drug development disappointment.

Sep 8, 2026·4 sources
00

Swiss institutions begin pilot test of CHFD stablecoin pegged to Swiss franc

Nine Swiss financial institutions including UBS, SIX, and TWINT launched a formal pilot test of CHFD, a stablecoin pegged to the Swiss franc, on September 8. The participants plan to test various use cases including automated transactions and settlement between financial institutions.

Sep 8, 2026·2 sources
00
Sep 7, 2026

UBS makes AI skills mandatory for graduate and intern hires in banking division

Swiss banking giant UBS will require all graduate and intern applicants to its Global Banking and Markets division to demonstrate AI skills in interviews starting in 2027, marking a shift from workforce reduction concerns to mandatory AI competency requirements in banking recruitment.

Sep 7, 2026·2 sources
00
Aug 13, 2026

Swiss government urges parliament to reject initiative opposing EU deal

The Swiss government recommended that parliament reject an initiative aimed at blocking a new agreement between Switzerland and the European Union. The deal would represent the biggest overhaul in bilateral economic relations in a generation.

Aug 13, 2026·2 sources
00
Aug 10, 2026

Canada sanctions Streit Group over supply of armored vehicles to Russian military

Canada imposed sanctions on UAE-based Streit Group, a Canadian-owned armored vehicle manufacturer, for supplying military equipment to Russia's National Guard used in the war against Ukraine. The sanctions complete a four-nation effort alongside Ukraine, the EU, and Switzerland.

Aug 10, 2026·4 sources
00
Aug 4, 2026

Cameroon's 93-year-old President Paul Biya reshuffles military leadership after 58-day absence from public view

President Paul Biya, the world's oldest head of state, has ordered a major military reshuffle through presidential decrees, replacing commanders in four of Cameroon's five joint military regions and promoting the Presidential Guard chief to brigadier general. The moves come as Biya has not been seen publicly for nearly two months, reportedly staying in Switzerland, sparking growing unease about his prolonged absence.

Aug 4, 2026·9 sources
00
Aug 3, 2026

Sandoz agrees to $450 million settlement with 43 US states over generic drug price-fixing allegations

Swiss generic drugmaker Sandoz has reached a settlement agreement to pay $450 million to 43 US states and territories to resolve antitrust litigation alleging anti-competitive conduct and price manipulation in the generic medicines market. The settlement includes no admission of wrongdoing and will not affect the company's financial guidance.

Aug 3, 2026·9 sources
00

Switzerland's Self-Regulatory Organization Model Draws Attention for Crypto Market Framework

Switzerland's SRO (Self-Regulatory Organization) system, which allows crypto firms to join private supervisory bodies for anti-money laundering compliance, is being highlighted as a model for enabling faster market entry while maintaining regulatory oversight.

Aug 3, 2026·3 sources
00
Jul 28, 2026

B-Secur and CSEM Partner to Develop Clinically-Validated Heart Monitoring for Wearable Devices

Swiss technology innovation center CSEM and biosensing technology company B-Secur announced a partnership to integrate clinically-validated heart monitoring capabilities into health wearables, combining CSEM's PPG-based vital signs monitoring expertise with B-Secur's biosensing technology.

Jul 28, 2026·1 source
00
Jul 27, 2026

Swiss Crypto Bank AMINA Explores Public Listing With Cantor Fitzgerald as Advisor

FINMA-regulated Swiss digital-asset bank AMINA is evaluating multiple paths to go public, including an IPO, SPAC merger, or reverse merger, with financial services firm Cantor Fitzgerald providing advisory services. The bank states its immediate priority remains securing strategic capital for growth.

Jul 27, 2026·5 sources
00
Jul 20, 2026

Samsung Biologics to Acquire Swiss Drugmaker PolyPeptide for $1.8 Billion in All-Cash Deal

Samsung Biologics announced an all-cash tender offer to acquire Switzerland's PolyPeptide Group AG for CHF 1.46 billion ($1.8B), at CHF 44.31 per share — a 6.1% premium to last close and ~40% to the April 10, 2026 undisturbed price, marking South Korea's largest biopharma acquisition.

Jul 20, 2026·6 sources
00
Jul 6, 2026

Novartis to Acquire UK Biotech Myricx Bio for Up to $1.5 Billion

Swiss pharmaceutical company Novartis has agreed to acquire UK-based biotechnology firm Myricx Bio for up to $1.5 billion, gaining access to experimental antibody-drug conjugates (ADCs) designed to deliver cancer treatments directly to tumors. The deal is expected to close in the second half of 2026.

Jul 6, 2026·3 sources
00
Jun 30, 2026

Traditionalist Catholic group defies Pope Leo XIV with unauthorized bishop consecrations in Switzerland

A breakaway group of traditionalist Catholics consecrated four bishops without papal consent in Écône, Switzerland, directly defying Pope Leo XIV's warnings and triggering automatic excommunications. The Society's actions represent the first major crisis of Pope Leo XIV's papacy and raise the specter of formal schism within the Catholic Church.

Jun 30, 2026·5 sources
00
Jun 29, 2026

Roche Launches Axelios Gene Sequencer to Challenge Illumina's Market Dominance

Swiss pharmaceutical giant Roche launched its long-awaited Axelios gene sequencer, aiming to break Illumina's leadership position in the next-generation sequencing market.

Jun 29, 2026·1 source
00
Jun 25, 2026

Oil tankers defy Iran warnings in Strait of Hormuz as prices fall to pre-war levels following peace talks

Multiple oil tankers sailed through the Strait of Hormuz on Thursday using a UN-recommended route despite Iranian threats, as oil prices dropped to pre-conflict levels following US-Iran talks in Switzerland that resulted in partial sanctions relief. One cargo ship was reportedly hit by a projectile during the passage.

Jun 25, 2026·6 sources
00
Jun 24, 2026

Record-breaking heatwave across Western Europe causes hundreds of deaths, with temperatures exceeding 110°F

A severe heatwave gripping Western Europe has caused at least 212 excess deaths in Spain since Sunday, with the UK and Switzerland recording their hottest-ever June temperatures. At least 101 million Europeans are affected by the extreme heat, which has also caused power outages and health emergencies across multiple countries.

Jun 24, 2026·6 sources
00
Jun 23, 2026

Iran and US conclude technical talks in Switzerland, agree to release $12bn in frozen assets amid cyber attack on Iranian banks

Technical negotiations between Iran and the United States in Switzerland have concluded successfully, with both sides expressing optimism and reaching an agreement to release $12 billion in frozen Iranian assets. The talks, aimed at implementing a ceasefire and ending hostilities, were followed by cyber attacks on Iranian state-owned banks.

Jun 23, 2026·3 sources
00
Jun 22, 2026

U.S. and Iran hold talks in Switzerland on ending Israel-Hezbollah war as northern Israel remains tense

U.S. Vice President JD Vance met with Iranian officials in Switzerland to negotiate a permanent end to the war between the U.S., Israel and Hezbollah that began in late February 2026, while Lebanon discusses deconfliction mechanisms and northern Israeli communities remain largely deserted.

Jun 22, 2026·3 sources
00

VP JD Vance announces progress in Iran nuclear talks, says Tehran agrees to allow inspectors

Vice President JD Vance said Monday that Iran has agreed to allow nuclear inspectors back into the country following talks with senior Iranian officials in Switzerland, describing the discussions as creating a 'good foundation' for a final deal to resolve the conflict between the two nations.

Jun 22, 2026·2 sources
00

Israel maintains fragile Lebanon ceasefire amid concerns over U.S.-Iran deal and troop withdrawal

Israel and Hezbollah are holding to a tense ceasefire with Israeli troops restricted to defensive positions in Lebanon, while Israeli officials express concern that new U.S.-Iran understandings reached in Switzerland are legitimizing Iranian influence and constraining Israel's operational freedom in the region.

Jun 22, 2026·5 sources
00
Jun 21, 2026

US authorizes Iranian Oil sales for 60 days as nuclear and security talks progress

The United States has authorized Iranian oil sales through August, easing decades-old sanctions following productive negotiations in Switzerland. The move comes as part of a broader push toward a final peace deal involving nuclear inspections and free transit through the Strait of Hormuz.

Jun 21, 2026·5 sources
00

US and Iran hold high-level talks in Switzerland, with conflicting accounts on nuclear inspections and sanctions relief

Vice President JD Vance met with senior Iranian officials in Switzerland, describing the talks as laying a "good foundation" for a deal to end hostilities. However, Iran disputed Vance's claim about allowing nuclear inspectors back, while President Trump threatened further attacks even as his administration waived sanctions and pursued financial concessions.

Jun 21, 2026·6 sources
00

Vance leads US-Iran peace talks in Switzerland amid Trump Threats and bipartisan Criticism

Vice President JD Vance conducted high-level negotiations with Iran in Switzerland following an apparent conflict, claiming progress toward peace while President Trump simultaneously issued threats that disrupted the talks. The negotiations have ended with technical discussions continuing, as both Democratic and Republican lawmakers express skepticism about any provisional deal.

Jun 21, 2026·6 sources
00

U.S. and Iran reach preliminary deal to end Lebanon War, begin nuclear talks

The United States and Iran have agreed to a ceasefire and 'road map' for negotiations following nearly four months of conflict, with Pakistan and Qatar mediating talks in Switzerland. The agreement includes partial lifting of U.S. sanctions on Iranian oil but leaves unresolved questions about Iran's nuclear program.

Jun 21, 2026·8 sources
00
Jun 20, 2026

US-Iran peace talks in Switzerland disrupted as Trump threats prompt Iranian walkout

High-level negotiations in Switzerland aimed at ending the Iran-US conflict faced immediate turmoil as Iranian negotiators walked out in protest of President Trump's threats to bomb Iran, even as Vice President Vance offered diplomatic overtures. The talks, which involve efforts to resolve the Lebanon war and reopen the Strait of Hormuz, are expected to continue at lower levels despite the tense start.

Jun 20, 2026·7 sources
00

US and Iran Complete First Round of Peace Talks in Switzerland, Technical Discussions to Continue

High-level negotiations between the United States and Iran concluded in Switzerland after the first round of talks aimed at achieving a permanent end to their conflict and cementing a ceasefire. Mediators Pakistan and Qatar reported "encouraging progress" and announced that technical-level discussions will continue through the week, despite tensions from President Trump's renewed threats of strikes and Iran's closure of the Strait of Hormuz.

Jun 20, 2026·6 sources
00
Jun 17, 2026

VP Vance delays Switzerland trip for Iran Nuclear talks, criticizes Israel over deal opposition

Vice President JD Vance postponed his trip to Geneva for nuclear negotiations with Iran while sharply criticizing Israeli leaders for their reaction to a preliminary U.S.-Iran agreement. The Trump administration deal, which leaves many core issues unresolved, has drawn strong opposition from Israel.

Jun 17, 2026·4 sources
00
Jun 13, 2026

VAR Technology Malfunction Sparks Controversy as Qatar Earns Historic First World Cup Point in 1-1 Draw with Switzerland

Qatar secured their first-ever World Cup point with a dramatic 95th-minute equalizer against Switzerland, but the match was overshadowed by a technical failure in FIFA's semi-automated offside system that prevented officials from releasing VAR images of a controversial penalty decision involving Switzerland's Remo Freuler.

Jun 13, 2026·9 sources
00
Jun 12, 2026

Switzerland to vote on referendum to cap population at 10 million

Switzerland is holding a referendum on June 14, 2026, on whether to cap its population at 10 million people, a proposal that has drawn comparisons to Brexit and could significantly impact the country's relationship with the European Union. The Alpine nation's population currently stands at approximately 9.1 million, having grown 23% since 2002.

Jun 12, 2026·9 sources
00
Jun 8, 2026

Roche enters licensing deal with Nurix Therapeutics for blood cancer drug worth up to $2.3-3 billion

Swiss pharmaceutical giant Roche has signed an exclusive licensing and collaboration agreement with Nurix Therapeutics for bexobrutinib, a protein degrader drug targeting B cell malignancies and blood cancers. The deal value is reported as up to $2.3 billion by one source and up to $3 billion by another.

Jun 8, 2026·2 sources
00
May 12, 2026

Sygnum Bank Integrates Crypto Trading into BancaStato's Online Banking Platform

Zurich-based Sygnum Bank has connected its regulated cryptocurrency services directly to BancaStato's online banking system, enabling the Swiss cantonal bank's clients in Ticino to buy, hold, and sell digital assets including Bitcoin, Ethereum, Litecoin, and Solana through their existing banking interface.

May 12, 2026·4 sources
00
May 9, 2026

SIX Digital Exchange Receives FINMA Approval to Merge with Traditional CSD

Swiss Financial Market Supervisory Authority (FINMA) approved SIX's plan to merge its digital central securities depository (SIX Digital Exchange) into its traditional CSD, SIX SIS, consolidating digital and traditional securities infrastructure.

May 9, 2026·1 source
00
May 7, 2026

Cruise ship with deadly hantavirus outbreak granted permission to dock in Spain's Canary Islands after evacuating three patients

A luxury cruise ship experiencing a hantavirus outbreak has been permitted by Spanish authorities to sail from Cape Verde to the Canary Islands, with three infected or suspected patients evacuated and nearly 150 people remaining isolated in their cabins. Swiss authorities confirmed a third case linked to the vessel.

May 7, 2026·4 sources
00
Apr 22, 2026

Roche Presents Multiple Sclerosis Drug Data Ahead of Regulatory Submission

Swiss drugmaker Roche presented latest clinical trial data for its experimental multiple sclerosis drug at a major conference, setting the stage for regulatory approval submissions, though safety questions remain under scrutiny.

Apr 22, 2026·1 source
00
Apr 9, 2026

XRP Products Lead $224 Million Weekly Crypto Fund Inflows, Outpacing Bitcoin

Global crypto investment products saw $224 million in net inflows last week, with XRP contributing $119.6 million (over half the total), while Switzerland accounted for 70% of global inflows.

Apr 9, 2026·4 sources
00
Apr 8, 2026

Six Swiss Banks Launch Unified Swiss Franc Stablecoin Sandbox

UBS, PostFinance, Sygnum, and four other Swiss financial institutions launched a 2026 sandbox to test Swiss franc stablecoin use cases and blockchain payment rails in controlled environment with real transactions.

Apr 8, 2026·3 sources
00
Apr 4, 2026

Trump Proposes 100% Tariffs on Pharmaceutical Imports Unless Companies Strike Pricing Deals

President Trump signed an executive order imposing up to 100% tariffs on certain branded pharmaceutical imports unless drugmakers negotiate pricing agreements with his administration, marking a major escalation in his drug pricing strategy.

Apr 4, 2026·4 sources
00

Top claims

  • ▪The FDA approved Roche Holding AG's oral breast cancer pill Wilserdly for patients with locally advanced or metastatic HR-positive, HER2-negative breast cancer
  • ▪The approval of Wilserdly expands Roche Holding AG's footprint in an emerging class of medicines aimed at reshaping treatment for HR-positive breast cancer
  • ▪ESR1 gene mutations indicate that an estrogen receptor-positive breast tumor is developing resistance to standard therapies

Topics

Cancer & OncologyCancer and Cancer TreatmentDrug safetyTargeted cancer therapyCancer treatmentDrug Policy, Pricing & ApprovalClinical trialsPharmaceutical IndustryFDA drug approvalContact tracingEbola outbreakGlobal healthInfectious Disease and OutbreaksOutbreak responseDisease surveillanceBiotechnologyAsthmaRespiratory diseasesDrug developmentBiotech innovationCOPDRare diseasesHealthcare industryOral healthVaccines and Immunization PolicyPublic healthPrenatal care & screeningChild healthPreventive medicineChild mortalityHematologyClinical guidelinesNigeria's imported Ebola case 2026Autoimmune disease treatmentsObservational researchAutoimmune diseaseStem cell therapyVaccination programsEpidemiologyKenya's Ebola outbreak 2026Bundibugyo virusEbola outbreak in the Democratic Republic of the Congo 2026Vaccine developmentUnited NationsSwitzerland–North Korea relationsDiplomacyNortheast Asian securityWorld affairsDiplomatic outreachAuthoritarian governance & repressionHuman rightsCrimes against humanityInternational criminal justiceWar crimes & accountabilityGlobal health securityCrypto investmentsBitcoin ETFsBitcoinInstitutional crypto adoptionCrypto regulationTariffs & trade warsInternational tradeVietnam–EFTA free-trade agreement 2026Trade agreements & blocsPharmaDrug discoveryRussia’s wartime governanceRussia-Ukraine warSanctions & economic countermeasuresAsset seizureBitcoin security & risksCrypto privacy & surveillanceBitcoin use casesAI data privacy & biometric surveillanceEuropean UnionCrypto exchangesCorporate restructuringCorporate governanceGeneric drugsMedication Pricing & AffordabilityHealthcare costsGeneric drugs & biosimilarsU.S. trade policyDrug Approval and Clinical TrialsDeFiBlockchain technologyStablecoinsTokenizationAI for developersFuture of workEU single market & competition policyEU expansionEU institutions & governanceDefense manufacturingArms trade & proliferationAuthoritarian governanceDrug pricing policyAntitrust & competitionCrypto market structureAnti-money laundering (AML)Regulatory frameworksBiomarkers & bloodwork testingWearables & Health TrackingCSEMB-SecurSecurities vs. commoditiesCrypto & banking regulationMergers & acquisitions (M&A)Pope Leo XIVShipping & logisticsOil marketStrait of Hormuz blockageIran WarEnergy security & geopoliticsIran war ceasefire and negotiationsHormuz closure & shippingPublic health emergenciesExtreme weather impactsEnergy infrastructureClimate changeCeasefires & negotiationsSwitzerland talksCyber warfareIran ceasefire US-Iran relationsIran ceasefire negotiationsIsrael-Lebanon warU.S. Middle East diplomacyMiddle East regional alliances & rivalriesIran's regional influenceLebanonIsrael–HezbollahMiddle EastArms control & disarmamentEnrichment & deal frameworksIran's nuclear programIran nuclear dealLebanon ceasefireIran & regional influenceForeign influence in the Middle EastOil prices & energy marketsPeace negotiations & peace agreementsIranian governmentIran war international responseU.S. domestic politics around Iran warPeace deal & signingNuclear arms controlU.S. Israel relationsFIFA World Cup 2026VR technologyMatch resultsNational sovereigntyImmigration policyFDA regulation & drug policyRegulatory complianceGovernment and Regulatory PolicyEthereumDigital asset regulationTokenized securitiesHealth surveillanceFDA drug approval processNew drug application (NDA) processUS healthcare regulationAltcoin marketsAltcoinsCrypto marketsStablecoin marketsPaymentsPublic healthcare

Related entities

United StatesNew YorkAbujaAfrica Centres for Disease Control and PreventionWorld Health OrganizationUgandaNigeriaNasdaqChinaCanadaApollo Global ManagementNetherlands